Gilead Sciences Net Income 2006-2019 | GILD

Gilead Sciences annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Gilead Sciences net income for the quarter ending December 31, 2019 was $2.696B, a 89766.67% increase year-over-year.
  • Gilead Sciences net income for the twelve months ending December 31, 2019 was $5.386B, a 1.26% decline year-over-year.
  • Gilead Sciences annual net income for 2019 was $5.386B, a 1.26% decline from 2018.
  • Gilead Sciences annual net income for 2018 was $5.455B, a 17.87% increase from 2017.
  • Gilead Sciences annual net income for 2017 was $4.628B, a 65.72% decline from 2016.
Gilead Sciences Annual Net Income
(Millions of US $)
2019 $5,386
2018 $5,455
2017 $4,628
2016 $13,501
2015 $18,108
2014 $12,101
2013 $3,075
2012 $2,592
2011 $2,804
2010 $2,901
2009 $2,636
2008 $1,979
2007 $1,585
2006 $-1,190
2005 $814
Gilead Sciences Quarterly Net Income
(Millions of US $)
2019-12-31 $2,696
2019-09-30 $-1,165
2019-06-30 $1,880
2019-03-31 $1,975
2018-12-31 $3
2018-09-30 $2,097
2018-06-30 $1,817
2018-03-31 $1,538
2017-12-31 $-3,865
2017-09-30 $2,718
2017-06-30 $3,073
2017-03-31 $2,702
2016-12-31 $3,108
2016-09-30 $3,330
2016-06-30 $3,497
2016-03-31 $3,566
2015-12-31 $4,683
2015-09-30 $4,600
2015-06-30 $4,492
2015-03-31 $4,333
2014-12-31 $3,487
2014-09-30 $2,731
2014-06-30 $3,656
2014-03-31 $2,227
2013-12-31 $792
2013-09-30 $789
2013-06-30 $773
2013-03-31 $722
2012-12-31 $763
2012-09-30 $676
2012-06-30 $712
2012-03-31 $442
2011-12-31 $665
2011-09-30 $741
2011-06-30 $746
2011-03-31 $651
2010-12-31 $629
2010-09-30 $705
2010-06-30 $712
2010-03-31 $855
2009-12-31 $802
2009-09-30 $673
2009-06-30 $571
2009-03-31 $589
2008-12-31 $560
2008-09-30 $496
2008-06-30 $435
2008-03-31 $488
2007-12-31 $371
2007-09-30 $398
2007-06-30 $408
2007-03-31 $407
2006-12-31 $-1,666
2006-09-30 $-52
2006-06-30 $265
2006-03-31 $263
2005-12-31 $282
2005-09-30 $179
2005-06-30 $196
2005-03-31 $157
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $94.011B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.140B 14.08
CSL (CSLLY) Australia $87.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $64.213B 58.28
Regeneron Pharmaceuticals (REGN) United States $55.175B 23.37
Biogen (BIIB) United States $52.430B 8.95
Illumina (ILMN) United States $41.254B 42.65
Alexion Pharmaceuticals (ALXN) United States $21.037B 9.75
Seattle Genetics (SGEN) United States $21.018B 0.00
Incyte (INCY) United States $18.786B 40.31
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.363B 614.08
Genmab (GMAB) Denmark $13.679B 10.62
Genmab (GNMSF) Denmark $13.202B 42.46
Galapagos (GLPG) Belgium $12.563B 38.39
Alnylam Pharmaceuticals (ALNY) United States $12.384B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.934B 51.10
Moderna (MRNA) United States $10.535B 0.00
BioNTech SE (BNTX) Germany $10.318B 0.00
Exact Sciences (EXAS) United States $9.263B 0.00
QIAGEN (QGEN) Netherlands $9.158B 27.92
BeiGene (BGNE) Cayman Islands $8.861B 0.00
Sarepta Therapeutics (SRPT) United States $7.776B 0.00
Bio-Techne Corp (TECH) United States $7.425B 50.82
ACADIA Pharmaceuticals (ACAD) United States $6.479B 0.00
Guardant Health (GH) United States $6.039B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.902B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.849B 15.46
Ascendis Pharma (ASND) Denmark $5.815B 0.00
Exelixis (EXEL) United States $5.378B 17.26
Repligen (RGEN) United States $5.034B 92.05
Acceleron Pharma (XLRN) United States $4.560B 0.00
Reata Pharmaceuticals (RETA) United States $4.474B 0.00
Immunomedics (IMMU) United States $4.045B 0.00
China Biologic Products (CBPO) China $3.936B 23.36
Global Blood Therapeutics (GBT) United States $3.573B 0.00
Blueprint Medicines (BPMC) United States $3.526B 0.00
Vir Biotechnology (VIR) United States $3.523B 0.00
Mirati Therapeutics (MRTX) United States $3.341B 0.00
MorphoSys AG (MOR) Germany $3.232B 0.00
Adaptive Biotechnologies (ADPT) United States $3.152B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.107B 0.00
Emergent Biosolutions (EBS) United States $3.077B 21.36
Zai Lab (ZLAB) China $2.984B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.936B 0.00
NeoGenomics (NEO) United States $2.616B 113.41
Amicus Therapeutics (FOLD) United States $2.598B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.514B 42.57
Deciphera Pharmaceuticals (DCPH) United States $2.422B 0.00
Arena Pharmaceuticals (ARNA) United States $2.352B 6.13
Alkermes (ALKS) Ireland $2.346B 185.88
Bluebird Bio (BLUE) United States $2.343B 0.00
Halozyme Therapeutics (HALO) United States $2.302B 0.00
UniQure (QURE) Netherlands $2.234B 0.00
MyoKardia (MYOK) United States $2.198B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.067B 0.00
Principia Biopharma (PRNB) United States $1.909B 0.00
Denali Therapeutics (DNLI) United States $1.863B 0.00
Fate Therapeutics (FATE) United States $1.836B 0.00
Amarin (AMRN) Ireland $1.800B 0.00
Alector (ALEC) United States $1.798B 0.00
Zymeworks (ZYME) Canada $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.616B 0.00
Arvinas (ARVN) United States $1.608B 0.00
Insmed (INSM) United States $1.591B 0.00
Viela Bio (VIE) United States $1.525B 0.00
Epizyme (EPZM) United States $1.517B 0.00
Akcea Therapeutics (AKCA) United States $1.503B 32.33
Dicerna Pharmaceuticals (DRNA) United States $1.335B 0.00
Ligand Pharmaceuticals (LGND) United States $1.291B 40.12
Inovio Pharmaceuticals (INO) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.159B 0.00
Coherus BioSciences (CHRS) United States $1.138B 13.55
Zealand Pharma (ZEAL) Denmark $1.130B 0.00
REGENXBIO (RGNX) United States $1.109B 0.00
Myriad Genetics (MYGN) United States $1.103B 19.46
PHARMA MAR SA (PHMMF) Spain $1.062B 0.00
NGM Biopharmaceuticals (NGM) United States $0.961B 0.00
Twist Bioscience (TWST) United States $0.936B 0.00
NextCure (NXTC) United States $0.928B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.855B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Beam Therapeutics (BEAM) United States $0.812B 0.00
Sangamo Therapeutics (SGMO) United States $0.789B 0.00
Adverum Biotechnologies (ADVM) United States $0.786B 0.00
Novavax (NVAX) United States $0.768B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.761B 0.00
I-Mab (IMAB) China $0.742B 0.00
Cytokineticsorporated (CYTK) United States $0.722B 0.00
Athenex (ATNX) United States $0.665B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Arcus Biosciences (RCUS) United States $0.663B 0.00
Retrophin (RTRX) United States $0.652B 0.00
GENFIT S.A (GNFT) France $0.627B 0.00
Cara Therapeutics (CARA) United States $0.624B 0.00
Bellus Health (BLU) Canada $0.615B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
Codexis (CDXS) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.582B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.569B 5.00
Compugen (CGEN) Israel $0.566B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.547B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.537B 0.00
ANI Pharmaceuticals (ANIP) United States $0.532B 9.59
Nabriva Therapeutics AG (NBRV) Ireland $0.530B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.529B 0.00
Castle Biosciences (CSTL) United States $0.526B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Frequency Therapeutics (FREQ) United States $0.473B 0.00
Athersys (ATHX) United States $0.473B 0.00
Verastem (VSTM) United States $0.463B 0.00
Intrexon (PGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AC Immune SA (ACIU) Switzerland $0.460B 11.74
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Sorrento Therapeutics (SRNE) United States $0.457B 0.00
Scholar Rock Holding (SRRK) United States $0.445B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Heska (HSKA) United States $0.439B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.422B 0.00
Cel-Sci (CVM) United States $0.421B 0.00
Vericel (VCEL) United States $0.420B 62.33
UROGEN PHARMA (URGN) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
Morphic Holding (MORF) United States $0.400B 0.00
Anika Therapeutics (ANIK) United States $0.398B 13.71
Cellectis S.A (CLLS) France $0.386B 0.00
MiMedx (MDXG) United States $0.386B 0.00
Agenus (AGEN) United States $0.385B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.380B 43.78
Adaptimmune Therapeutics (ADAP) United Kingdom $0.368B 0.00
CytomX Therapeutics (CTMX) United States $0.354B 0.00
Mersana Therapeutics (MRSN) United States $0.352B 0.00
PDL BioPharma (PDLI) United States $0.345B 10.33
Kala Pharmaceuticals (KALA) United States $0.328B 0.00
Merus (MRUS) Netherlands $0.319B 0.00
Pfenex (PFNX) United States $0.303B 442.00
Syros Pharmaceuticals (SYRS) United States $0.302B 0.00
Cellular Biomedicine (CBMG) United States $0.293B 0.00
Precision BioSciences (DTIL) United States $0.287B 0.00
NantKwest (NK) United States $0.281B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.277B 0.00
Kamada (KMDA) Israel $0.272B 11.30
WAVE Life Sciences (WVE) Singapore $0.267B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.263B 0.00
Dynavax Technologies (DVAX) United States $0.259B 0.00
Avid Bioservices (CDMO) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.254B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.249B 0.00
Stemline Therapeutics (STML) United States $0.238B 0.00
Gritstone Oncology (GRTS) United States $0.229B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Albireo Pharma (ALBO) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.222B 0.00
MannKind (MNKD) United States $0.211B 0.00
Geron (GERN) United States $0.210B 0.00
Alcobra (ARCT) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Aduro Biotech (ADRO) United States $0.201B 0.00
Abeona Therapeutics (ABEO) United States $0.192B 0.00
XOMA (XOMA) United States $0.188B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.187B 1.68
Protagonist Therapeutics (PTGX) United States $0.177B 0.00
Prometic Life Sciences (LMNL) Canada $0.176B 0.00
HOOKIPA Pharma (HOOK) United States $0.174B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.169B 0.00
VBI Vaccines (VBIV) United States $0.167B 0.00
IVERIC Bio (ISEE) United States $0.162B 0.00
Selecta Biosciences (SELB) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.153B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Dyadic (DYAI) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
VolitionRX (VNRX) United States $0.141B 0.00
Exicure (XCUR) United States $0.140B 0.00
Aytu Bioscience (AYTU) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Affimed (AFMD) Germany $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Antibe Therapeutics (ATBPF) Canada $0.133B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Cerecor (CERC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.123B 0.00
Enzo Biochem (ENZ) United States $0.116B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.113B 4.45
Northwest Biotherapeutics (NWBO) United States $0.112B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Aptinyx (APTX) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.094B 2.57
TELA Bio (TELA) United States $0.091B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
IBio (IBIO) United States $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
Five Prime Therapeutics (FPRX) United States $0.087B 0.00
CorMedix Inc (CRMD) United States $0.084B 0.00
Happiness Biotech Group (HAPP) China $0.079B 0.00
Orgenesis (ORGS) United States $0.076B 4.47
Pluristem Therapeutics (PSTI) Israel $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Eton Pharmaceuticals (ETON) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Synlogic (SYBX) United States $0.056B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Catalyst Biosciences (CBIO) United States $0.053B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Advaxis (ADXS) United States $0.037B 0.00
Protalix BioTherapeutics (PLX) Israel $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.035B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
Celsion (CLSN) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Menlo Therapeutics (MNLO) United States $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Curis (CRIS) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00